After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
|Articles|September 22, 2015
Shaji Kumar on Treatment-Related Adverse Events From Monoclonal Antibodies
Author(s)Shaji Kumar
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
Advertisement
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
The main adverse event that is seen is infusion reactions, Kumar says. These reactions are easily managed and, even so, usually go away on their own.
Advertisement
Related to this article
Emma Halligan found connection at a free New Jersey retreat for women with cancer, which held its annual walk and 5K on Oct. 17.
Diagnosed with stage 4 breast cancer weeks after giving birth, Eileen Carter explains why getting a second opinion changed the course of her care.
Noah Elliott, now a Paralympic snowboarder, counted small wins during inpatient chemotherapy and found inspiration in the youngest children on his hospital floor.
Advertisement
Advertisement
Trending on CURE
1
New Myelofibrosis Guidelines Back Wider Gene Testing at Diagnosis
2
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
3
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
4
Why Cancer Screening Remains Important for Long-Term Cancer Survivors
5